TransMedics Group Inc (TMDX)
Net profit margin
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Net income | US$ in thousands | 35,464 | -25,028 | -36,231 | -44,215 | -28,748 |
Revenue | US$ in thousands | 441,540 | 241,623 | 93,459 | 30,262 | 25,639 |
Net profit margin | 8.03% | -10.36% | -38.77% | -146.11% | -112.13% |
December 31, 2024 calculation
Net profit margin = Net income ÷ Revenue
= $35,464K ÷ $441,540K
= 8.03%
Net profit margin is a key financial ratio that reflects a company's profitability by indicating the percentage of revenue that translates into net income after accounting for all expenses. Over the past five years, TransMedics Group Inc's net profit margin has shown significant fluctuations.
As of December 31, 2020, the company reported a net profit margin of -112.13%, indicating that its expenses exceeded its revenue, resulting in a net loss. This negative margin improved slightly by December 31, 2021, but still remained in negative territory at -146.11%.
In the following years, there was a notable improvement in the net profit margin. By December 31, 2022, the margin stood at -38.77%, showing a significant reduction in losses. This positive trend continued into December 31, 2023, with the net profit margin improving further to -10.36%.
The most noteworthy development occurred by December 31, 2024, when TransMedics Group Inc reported a positive net profit margin of 8.03%. This marked a significant turnaround for the company, as it shifted from incurring losses to generating profits.
Overall, the analysis of TransMedics Group Inc's net profit margin over the past five years reflects a progression from substantial losses to eventual profitability, indicating an improving financial performance and potentially better management of expenses relative to revenue.
Peer comparison
Dec 31, 2024